Affiliations of authors: Section of Cardiovascular Medicine, Department of Medicine, Department of Radiology and Biomedical Imaging, Yale University School of Medicine, New Haven, CT, USA.
UCLA Cardio-Oncology Program, Division of Cardiology, Department of Medicine, University of California at Los Angeles, Los Angeles, CA, USA.
J Natl Cancer Inst. 2021 May 4;113(5):513-522. doi: 10.1093/jnci/djaa177.
In response to the coronavirus disease 2019 (COVID-19) pandemic, the Cardio-Oncology and Imaging Councils of the American College of Cardiology offers recommendations to clinicians regarding the cardiovascular care of cardio-oncology patients in this expert consensus statement. Cardio-oncology patients-individuals with an active or prior cancer history and with or at risk of cardiovascular disease-are a rapidly growing population who are at increased risk of infection, and experiencing severe and/or lethal complications by COVID-19. Recommendations for optimizing screening and monitoring visits to detect cardiac dysfunction are discussed. In addition, judicious use of multimodality imaging and biomarkers are proposed to identify myocardial, valvular, vascular, and pericardial involvement in cancer patients. The difficulties of diagnosing the etiology of cardiovascular complications in patients with cancer and COVID-19 are outlined, along with weighing the advantages against risks of exposure, with the modification of existing cardiovascular treatments and cardiotoxicity surveillance in patients with cancer during the COVID-19 pandemic.
针对 2019 年冠状病毒病（COVID-19）大流行，美国心脏病学会的心血管肿瘤学和影像学委员会在这份专家共识声明中为临床医生提供了关于心血管肿瘤学患者心血管护理的建议。心血管肿瘤学患者是指有活动性或既往癌症病史、有或有心血管疾病风险的人群，他们感染风险增加，COVID-19 导致严重和/或致命并发症的风险增加。讨论了优化筛查和监测就诊以检测心功能障碍的建议。此外，还提出了明智使用多模态成像和生物标志物的建议，以识别癌症患者的心肌、瓣膜、血管和心包受累情况。概述了在癌症患者中诊断心血管并发症病因的困难，以及权衡 COVID-19 大流行期间癌症患者的暴露风险与获益，同时修改现有的心血管治疗方法和心脏毒性监测。
